Recommended Talks:

2nd Env Manufacturing Workshop
Choosing the right protein
September 2016
Hans Langedijk, Janssen, J&J
2nd Env Manufacturing Workshop
Case study of formulating protein for P5
September 2016
Antu Dey, International AIDS Vaccine Initiative (IAVI)
Product Development Boot Camp
Preclinical data and regulatory considerations
November 2015
Jim Ackland, Global Biosolutions
Design, Test, Repeat: Paths to Elicit Neutralizing Antibodies - A virtual Mini Symposium
May 2015
Introduction
Bargavi Thyagarajan, Global HIV Vaccine Enterprise
Chair
Robin Shattock, Imperial College London
HIV-1 antibody lineages: Implications for vaccine design
John Mascola, Vaccine Research Center, NIAID, NIH
Sequential Env Immunisations as a Path to an HIV Vaccine
Larry Liao, Duke Human Vaccine Institute, Duke University School of Medicine
Native Flexibly Linked Well-ordered Trimers
Richard Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute
Diversity of HIV-1 Env Vaccine-Induced Antibody Responses
Gunilla Hedestam, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
Moderator
Penny Moore, National Institute for Communicable Diseases South Africa
Robin Shattock, Imperial College London
Panelist
John Mascola, Vaccine Research Center, NIAID, NIH
Larry Liao, Duke Human Vaccine Institute, Duke University School of Medicine
Gunilla Hedestam, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
Richard Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute
2nd Workshop on Prevention Trials in Infants Born to HIV-Positive Mothers
bNAbs development in infants
February 2017
Philip Goulder, Oxford University

Search:

Search term(s):

Search for text in:

separate each search
term with a space

Multiple terms:

Conference Years:

Content Type:

Latest Additions

Meeting Format: 1 day meeting   |   April 2016
Various stakeholders share past experiences of innovative uses of technologies and discuss what could be adopted in future HIV clinical trials. Webcasts | Learn More
Meeting Format: 2 day meeting   |   November 2015
Presentations by product development experts, introduction to new resources, and active learning through discussion with peers and experts. Webcasts | Learn More
Meeting Format: 3 day meeting   |   October 2015
A webcast featuring several of the presentations of the 2015 Cent Gardes meeting, addressing a range of topics pertinent to HIV vaccine research. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   September 2015
Immunologists and HIV vaccine experts review recent developments in germinal center (GC) biology and evaluate implications of defective GC physiology. Webcasts | Learn More
Meeting Format: 2 hour meeting   |   July 2015
An interactive session at IAS 2015 to explore the rapidly evolving HIV vaccine field, ranging from vaccine design to development and testing. Webcasts | Learn More
Meeting Format: 2 day meeting   |   June 2015
An exchange of information and experiences and a status update of ongoing efforts related to the GMP manufacturing of HIV ENV proteins. Webcasts | Learn More
Meeting Format: 2 hour webinar   |   May 2015
A focus on immunogens design, novel immunization regimens, and tracking of antibody responses with the goal of eliciting broadly neutralizing antibodies. Webcasts | Learn More
Meeting Format: 1 day meeting   |   May 2015
Review the landscape of past, current and future nucleic acid delivery technologies and learn from the experience of representative clinical trials. Webcasts | Learn More
Meeting Format: 2 hour webinar   |   September 2014
Review the potential roles of the complement system in modulating humoral immunity and discuss the potential to advance the field in a new direction. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   November 2013
A consultation to help determine the intersection between therapeutic and preventive vaccines and to provide recommendations for future developments. Webcasts | Learn More
1 2 3